--- title: "Twist Bioscience (TWST) stock: news and investor profile" url: "https://aibio.space/companies/twist-bioscience/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Twist Bioscience Corp (NASDAQ: TWST), United States. Listing facts, related biotech companies and news on aibio.space." --- TWST Twist Bioscience Corp NASDAQ · United States # Twist Bioscience (TWST) news Twist Bioscience Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TWST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Twist Bioscience news We have not published a story on Twist Bioscience yet. When there is news, it will appear here. ## Twist Bioscience at a glance - **Ticker**: TWST - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $166.8 million ### Related companies - [FEMASYS INC](https://aibio.space/companies/femasys/) NASDAQ: FEMY - [ICON](https://aibio.space/companies/icon/) NASDAQ: ICLR - [CVRx](https://aibio.space/companies/cvrx/) NASDAQ: CVRX - [Harvard Apparatus Regenerative Technology](https://aibio.space/companies/harvard-apparatus-regenerative-technology/) OTC: HRGN - [Envista Holdings](https://aibio.space/companies/envista/) NYSE: NVST - [Adastra Holdings](https://aibio.space/companies/adastra/) OTC: XTXXF - [Sanara MedTech](https://aibio.space/companies/sanara-medtech/) NASDAQ: SMTI - [TRAFALGAR INTERNATIONAL, INC.](https://aibio.space/companies/trafalgar-international-gcand/) OTC: GCAND ### Also on NASDAQ - [Tyra Biosciences](https://aibio.space/companies/tyra-biosciences/) TYRA - [Benitec Biopharma](https://aibio.space/companies/benitec-biopharma/) BNTC - [Lucid Diagnostics](https://aibio.space/companies/lucid-diagnostics/) LUCD - [Recursion Pharmaceuticals](https://aibio.space/companies/recursion-pharmaceuticals/) RXRX - [CYPHERPUNK TECHNOLOGIES INC.](https://aibio.space/companies/cypherpunk-technologies/) CYPH - [Fulcrum Therapeutics](https://aibio.space/companies/fulcrum-therapeutics/) FULC ## Twist Bioscience annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Research and development | [$80.3 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | [$90.9 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | | Net income (loss) | [-$77.7 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | [-$208.7 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | | Cash from operations | [-$47.6 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | [-$64.1 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | | Cash and equivalents | [$183.0 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128026000047/) | [$226.3 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | | Short-term investments | [$49.4 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128026000047/) | [$50.1 million](https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $117.4 million, plus short-term investments of $49.4 million, $166.8 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Twist Bioscience What is the ticker symbol of Twist Bioscience? Twist Bioscience Corp trades under the ticker TWST on NASDAQ. Where is Twist Bioscience listed? Twist Bioscience Corp is listed on NASDAQ. Which country or territory is Twist Bioscience listed under? Our directory records Twist Bioscience Corp under United States. Does aibio.space cover Twist Bioscience? aibio.space lists Twist Bioscience Corp among 2,820 public biotech companies and publishes its news here as stories appear. Is Twist Bioscience profitable? Twist Bioscience Corp reported a net loss of $77.7 million for the fiscal year ended Sep 30, 2025, and used $47.6 million of cash in operations, per its annual report to the SEC. How much does Twist Bioscience spend on research and development? $80.3 million in the fiscal year ended Sep 30, 2025, per its annual report. How much cash does Twist Bioscience have? $166.8 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Twist Bioscience Members talk about Twist Bioscience (TWST). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Twist Bioscience, newest first. Each line links the filing it comes from. 1. 2026-08-04 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1581280/000110465926090503/tm2622018-1_424b5.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TWST on TradingView](https://www.tradingview.com/symbols/NASDAQ-TWST/). ## Listing details Twist Bioscience Corp is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TWST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Twist Bioscience Corp - **Ticker**: TWST - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/twist-bioscience/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Twist Bioscience (TWST) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/twist-bioscience/